Abstract:e15603 Background: Our recent single-cell transcriptomic data indicate that colorectal cancer (CRC) can be classified into two major epithelial subtypes: iCMS2 and iCMS31. iCMS3 CRC includes MSI-H and one-third of MSS tumors. The latter are enriched in KRAS, PIK3CA, and BRAF mutations. The iCMS2 subtype often exhibits chromosome instability, including copy number changes in specific chromosome regions. These genomic alterations may be associated with distinct histomorphological features, which can be assessed using hematoxylin and eosin (H&E) staining. Methods: To test this hypothesis, we acquired and analyzed multiplexed Fluorescence in situ Hybridization (mFISH) and immunofluorescence (IF) staining data from 84 samples from 32 patients. For the mFISH data, we targeted 464 genes, encompassing major cell lineage markers and genes differentially expressed between iCMS2 and iCMS3 patient subtypes. Images were acquired over 31 hybridization rounds. Following the acquisition of the mFISH data, the same tissue section was stained with anti-EPCAM, anti-CD45 and anti-Vimentin antibodies to delineate cell boundaries and distinguish between the major cell lineages. Subsequently, all crypts were segmented based on their EPCAM and VIM stains, and parameters such as crypt size (number of pixels), crypt depth (distance to the nearest VIM signal), and fractal dimension were calculated for each crypt. The output of crypt segmentation was then integrated with mFISH RNA data to elucidate cell type proportions and gene expression profiles across and within individual segmented crypts. Results: Here, we found that iCMS2 crypts, in contrast to iCMS3 crypts, are significantly larger, deeper, and have higher fractal dimension. Additionally, our mFISH data demonstrated that iCMS2 tumors contain a higher proportion of undifferentiated (stem-like) cells, while iCMS3 tumors have a higher proportion of goblet (terminally differentiated) cells. The presence of larger and deeper crypts in iCMS2 may suggest a distinct cell state. Indeed, we identified specific genes whose expression was correlated with crypt depth. Conclusions: Our preliminary results suggest that these two iCMS subtypes exhibit distinct histomorphological features, which can be employed as practical and cost-effective companion diagnostics to assist in the pathological discrimination of these subtypes. References: 1 Joanito, I., Wirapati, P., Zhao, N. et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat Genet 54, 963–975 (2022).

Identification of unique rectal cancer-specific subtypes

Identification of a Novel Immune-Related Prognostic Model for Patients with Colorectal Cancer Based on 3 Subtypes.

Multi-region and Single-Cell Sequencing Reveal Variable Genomic Heterogeneity in Rectal Cancer

Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines

Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges

The consensus molecular subtypes of colorectal cancer

Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy

Colorectal Cancer Stem Cell Subtypes Orchestrate Distinct Tumor Microenvironments

Delineating histomorphological signatures of iCMS subtypes in colorectal cancer using multiplexed fluorescence-in-situ hybridization.

Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses

Poor-prognosis Locally Advanced Rectal Cancer is Defined by a Molecularly Distinct Subtype

Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics

Refining colorectal cancer classification and clinical stratification through a single-cell atlas

Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics

Comprehensive Molecular Profiling of Colorectal Cancer with Situs Inversus Totalis by Next-Generation Sequencing

Chemokine‐ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients

From tumour heterogeneity to advances in precision treatment of colorectal cancer

Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis

Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer

Subtyping of Microsatellite Instability-High Colorectal Cancer